cathepsin C inhibitors (Axys)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecathepsin C inhibitors (Axys)
Drug Alias NameDPP-1 inhibitors (Khepri)cathepsin C inhibitors (Khepri)DPP-1 inhibitors (Axys)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKhepri Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKhepri PharmaceuticalsCelera
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A